The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
- PMID: 32057769
- PMCID: PMC7114094
- DOI: 10.1016/j.antiviral.2020.104742
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
Abstract
In 2019, a new coronavirus (2019-nCoV) infecting Humans has emerged in Wuhan, China. Its genome has been sequenced and the genomic information promptly released. Despite a high similarity with the genome sequence of SARS-CoV and SARS-like CoVs, we identified a peculiar furin-like cleavage site in the Spike protein of the 2019-nCoV, lacking in the other SARS-like CoVs. In this article, we discuss the possible functional consequences of this cleavage site in the viral cycle, pathogenicity and its potential implication in the development of antivirals.
Keywords: 2019-nCoV; Antivirals; Furin; Maturation protease; SARS-CoV; Spike protein.
Copyright © 2020 Elsevier B.V. All rights reserved.
Figures


Similar articles
-
Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.Biophys Chem. 2020 Sep;264:106420. doi: 10.1016/j.bpc.2020.106420. Epub 2020 Jun 29. Biophys Chem. 2020. PMID: 32622243 Free PMC article.
-
Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein.J Clin Pathol. 2020 Jul;73(7):366-369. doi: 10.1136/jclinpath-2020-206658. Epub 2020 May 6. J Clin Pathol. 2020. PMID: 32376714 Review.
-
Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence.J Phys Chem Lett. 2020 Aug 20;11(16):6655-6663. doi: 10.1021/acs.jpclett.0c01698. Epub 2020 Aug 5. J Phys Chem Lett. 2020. PMID: 32787225
-
Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity.Int J Infect Dis. 2021 Feb;103:611-616. doi: 10.1016/j.ijid.2020.10.033. Epub 2020 Oct 17. Int J Infect Dis. 2021. PMID: 33075532 Free PMC article.
-
Properties of Coronavirus and SARS-CoV-2.Malays J Pathol. 2020 Apr;42(1):3-11. Malays J Pathol. 2020. PMID: 32342926 Review.
Cited by
-
Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.Med Hypotheses. 2020 Nov;144:110027. doi: 10.1016/j.mehy.2020.110027. Epub 2020 Jun 26. Med Hypotheses. 2020. PMID: 32758873 Free PMC article.
-
Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases.J Biomol Struct Dyn. 2022 Feb;40(3):1363-1386. doi: 10.1080/07391102.2020.1824814. Epub 2020 Sep 28. J Biomol Struct Dyn. 2022. PMID: 32981461 Free PMC article.
-
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus.Front Pharmacol. 2020 Aug 26;11:1224. doi: 10.3389/fphar.2020.01224. eCollection 2020. Front Pharmacol. 2020. PMID: 32982720 Free PMC article. Review.
-
Outbreak of COVID-19: An emerging global pandemic threat.Biomed Pharmacother. 2020 Sep;129:110499. doi: 10.1016/j.biopha.2020.110499. Epub 2020 Jul 4. Biomed Pharmacother. 2020. PMID: 32768974 Free PMC article. Review.
-
The Basicity Makes the Difference: Improved Canavanine-Derived Inhibitors of the Proprotein Convertase Furin.ACS Med Chem Lett. 2021 Feb 9;12(3):426-432. doi: 10.1021/acsmedchemlett.0c00651. eCollection 2021 Mar 11. ACS Med Chem Lett. 2021. PMID: 33732412 Free PMC article.
References
-
- Anderson E.D., Thomas L., Hayflick J.S., Thomas G. Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed α1-antitrypsin variant. J. Biol. Chem. 1993;268:24887–24891. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous